All of the top performers in August were the stocks focusing on large buybacks with relatively small dividends. Strategies How stock buybacks lifted the Net Payout Yields model
U.S. stocks stack up well vs. the rest of the world based on valuation, even as the price charts hint at the possibility of coming U.S. outperformance. Outlook The S&P 500 vs. the world
In most biotech life cycles, there are always several defining moments that could make or break their valuations Strategies Anatomy of a Biotech Trade: Transcept Pharmaceuticals
Investors poured $30 billion into taxable-bond funds and another $5.6 billion into municipal-bond funds in August. Strategies Behind investors’ current love affair with fixed income assets
Two important signals are saying that stocks are not overbought at these levels and the longer-term market trend is still to the upside. Outlook It might not be too late to get in on …
The world still has a growing thirst for oil amid the continued worries of an economic slowdown. That may benefit some oil and gas MLPs. Strategies Rising oil demand may benefit some MLPs